Skip to main content
. 2020 Winter;19(1):18–30. doi: 10.22037/ijpr.2019.14599.12519

Table 4.

Number of samples and patients which were examined for MRP and NDM

Samples (n) Patients (n Total; Women %) Samples with not Detectable Parent Substance
63 38 (60.3) 1